Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) Treatment Market Insights: Growth, Share, Value, Size, and Trends By 2032

The global cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) treatment market size was valued at USD 3.02 billion in 2024 and is expected to reach USD 4.30 billion by 2032, at a CAGR of 4.50% during the forecast period.